Your browser doesn't support javascript.
loading
Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
Ramos-Casals, Manuel; Maria, Alexandre; Suárez-Almazor, María E; Lambotte, Olivier; Fisher, Benjamin A; Hernández-Molina, Gabriela; Guilpain, Philippe; Pundole, Xerxes; Flores-Chávez, Alejandra; Baldini, Chiara; Bingham Iii, Clifton O; Brito-Zerón, Pilar; Gottenberg, Jacques-Eric; Kostine, Marie; Radstake, Timothy R D; Schaeverbeke, Thierry; Schulze-Koops, Hendrik; Calabrese, Leonard; Khamashta, Munther A; Mariette, Xavier.
Afiliação
  • Ramos-Casals M; Department of Autoimmune Diseases, ICMiD, Barcelona; Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona; and Department of Medicine, University of Barcelona, Hospital Clínic, Barcelona, Spain. mramos@clinic.cat
  • Maria A; Department of Internal Medicine Multi-Organic Diseases, Local Referral Center for Autoimmune Diseases, Saint Eloi Hospital, Montpellier University Hospital, France.
  • Suárez-Almazor ME; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lambotte O; APHP Médecine Interne/Immunologie Clinique, Hôpital Bicêtre, Paris, and Université Paris Sud - INSERM U1184 - CEA, Immunology of Viral Infections and Autoimmune Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses & Le Kremlin- Bicêtre, France.
  • Fisher BA; Institute of Inflammation and Ageing, University of Birmingham; and National Institute of Health Research Birmingham Biomedical Research Centre and Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Hernández-Molina G; Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Subirán, México City, Mexico.
  • Guilpain P; Department of Internal Medicine Multi-Organic Diseases, Local Referral Center for Autoimmune Diseases, Saint Eloi Hospital, Montpellier University Hospital, France.
  • Pundole X; Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Flores-Chávez A; Department of Autoimmune Diseases, ICMiD, Barcelona, Spain.
  • Baldini C; Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  • Bingham Iii CO; Department of Rheumatology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Brito-Zerón P; Department of Autoimmune Diseases, ICMiD, Barcelona, and Department of Internal Medicine, Hospital CIMA-Sanitas, Barcelona, Spain.
  • Gottenberg JE; Dept. of Rheumatology, Strasbourg University Hospital, National Centre For Rare Systemic Autoimmune Diseases, CNRS, Institut de Biologie Moléculaire et Cellulaire, Immunologie, Immunopathologie et Chimie Thérapeutique, University of Strasbourg, France.
  • Kostine M; Department of Rheumatology, Centre Hospitalier Universitaire, Bordeaux, France.
  • Radstake TRD; Department of Rheumatology/Clinical Immunology, University Medical Center Utrecht, The Netherlands.
  • Schaeverbeke T; Department of Rheumatology, Centre Hospitalier Universitaire, Bordeaux, France.
  • Schulze-Koops H; Department of Rheumatology/Clinical Immunology, Ludwig-Maximilians-University Munich, Germany.
  • Calabrese L; Department of Rheumatic/Immunologic Diseases, Cleveland Clinic University, Cleveland, OH, USA.
  • Khamashta MA; Lupus Clinic, Rheumatology Department, Dubai Hospital, UAE.
  • Mariette X; Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique ­ Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France.
Clin Exp Rheumatol ; 37 Suppl 118(3): 114-122, 2019.
Article em En | MEDLINE | ID: mdl-31464670
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Espanha